Burkett Financial Services’s Gilead Sciences GILD Stock Holding History

Burkett Financial Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.5K	Buy	138 +1	+0.7%	+$132	0.01%	156
2026 Q1	$19.2K	Hold	137	–	–	0.01%	149
2025 Q4	$16.8K	Buy	137 +1	+0.7%	+$122	0.01%	144
2025 Q3	$15.1K	Buy	136 +1	+0.7%	+$114	0.01%	144
2025 Q2	$15K	Buy	135 +1	+0.7%	+$106	0.01%	136
2025 Q1	$15K	Buy	134 +1	+0.8%	+$103	0.01%	148
2024 Q4	$12.3K	Buy	133 +1	+0.8%	+$90	0.01%	137
2024 Q3	$11.1K	Buy	132 +1	+0.8%	+$76	﹤0.01%	131
2024 Q2	$8.99K	Buy	131 +1	+0.8%	+$67	﹤0.01%	142
2024 Q1	$9.49K	Buy	130 +2	+2%	+$154	﹤0.01%	143
2023 Q4	$10.4K	Buy	+128	New	+$9.96K	0.01%	134

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Burkett Financial Services's GILD Position: Q2 2026 in Review

Burkett Financial Services increased its Gilead Sciences (GILD) stake by 0.73% in Q2 2026, buying an estimated $132 and bringing the position to 138 shares worth $17.5K. The position accounts for 0.01% of the portfolio, ranked #156.

Burkett Financial Services first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.2K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Burkett Financial Services held 138 shares of Gilead Sciences worth $17.5K as of Q2 2026.
Burkett Financial Services bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
Gilead Sciences made up 0.01% of Burkett Financial Services's portfolio in Q2 2026, its #156 holding.
Burkett Financial Services first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Burkett Financial Services's Gilead Sciences position peaked at $19.2K in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Burkett Financial Services's 13F filing for Q2 2026, filed 2 Jul 2026.